Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gil D Rabinovici

Showing results (1-10 of 395) with videos related to

Pageof 40
Sort By:
The New England Journal of Medicine|July 28, 2021
Controversy and Progress in Alzheimer's Disease - FDA Approval of AducanumabGil D Rabinovici
Brain : a Journal of Neurology|March 26, 2016
Amyloid biomarkers: pushing the limits of early detectionGil D Rabinovici
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentGil D Rabinovici
JAMA Neurology|January 27, 2015
The translational journey of brain β-amyloid imaging: from positron emission tomography to autopsy to clinicGil D Rabinovici
Continuum (Minneapolis, Minn.)|February 2, 2019
Late-onset Alzheimer DiseaseGil D Rabinovici
Nature Medicine|July 6, 2021
Dominantly inherited Alzheimer's disease: a compass for drug developmentGil D Rabinovici
The Lancet. Neurology|November 15, 2025
Progress in Alzheimer's disease: The Lancet SeriesGil D Rabinovici
JAMA|July 26, 2017
Advances and Gaps in Understanding Chronic Traumatic Encephalopathy: From Pugilists to American Football PlayersGil D Rabinovici
Alzheimer'S Research & Therapy|November 11, 2011
Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applicationsRobert Laforce, Gil D Rabinovici
JAMA Neurology|July 28, 2024
Blood-Based Biomarkers for Alzheimer Disease-Ready for Primary Care?Lawren VandeVrede, Gil D Rabinovici
Pageof 40

Showing results (1-10 of 395) with videos related to

Sort By:
Pageof 40
The New England Journal of Medicine|July 28, 2021
Controversy and Progress in Alzheimer's Disease - FDA Approval of AducanumabGil D Rabinovici
Brain : a Journal of Neurology|March 26, 2016
Amyloid biomarkers: pushing the limits of early detectionGil D Rabinovici
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentGil D Rabinovici
JAMA Neurology|January 27, 2015
The translational journey of brain β-amyloid imaging: from positron emission tomography to autopsy to clinicGil D Rabinovici
Continuum (Minneapolis, Minn.)|February 2, 2019
Late-onset Alzheimer DiseaseGil D Rabinovici
Nature Medicine|July 6, 2021
Dominantly inherited Alzheimer's disease: a compass for drug developmentGil D Rabinovici
The Lancet. Neurology|November 15, 2025
Progress in Alzheimer's disease: The Lancet SeriesGil D Rabinovici
JAMA|July 26, 2017
Advances and Gaps in Understanding Chronic Traumatic Encephalopathy: From Pugilists to American Football PlayersGil D Rabinovici
Alzheimer'S Research & Therapy|November 11, 2011
Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applicationsRobert Laforce, Gil D Rabinovici
JAMA Neurology|July 28, 2024
Blood-Based Biomarkers for Alzheimer Disease-Ready for Primary Care?Lawren VandeVrede, Gil D Rabinovici
Pageof 40